Zoetis (ZTS) insider files to sell 2,346 shares under Rule 144

Rhea-AI Filing Summary

Zoetis Inc. insider plans Rule 144 sale of common stock. A filing indicates an intention to sell 2,346 shares of Zoetis common stock through Merrill Lynch on the NYSE, with an aggregate market value of $298,741.99 and 422,127,709 shares outstanding.

The shares come from equity compensation, including vested restricted stock units and performance share awards granted under the issuer’s equity compensation plan. The seller, identified as Robert Polzer, previously sold 3,662 shares of common stock in the past three months for gross proceeds of $472,727.58.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	2346	298741.99	422127709	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/12/2022	Vesting of restricted stock unit award	Zoetis Inc.			287	02/12/2022	Granted as part of issuer equity compensation plan
Common Stock	02/12/2022	Vesting of performance share award	Zoetis Inc.			601	02/12/2022	Granted as part of issuer equity compensation plan
Common Stock	02/08/2025	Vesting of restricted stock unit award	Zoetis Inc.			473	02/08/2025	Granted as part of issuer equity compensation plan
Common Stock	02/08/2025	Vesting of performance share award	Zoetis Inc.			985	02/08/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Polzer 10 SYLVAN WAY PARSIPPANY NJ 07054	Common Stock	02/13/2026	3662	472727.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Zoetis (ZTS) disclose?

The filing discloses an intention to sell 2,346 Zoetis common shares under Rule 144. The planned sale, via Merrill Lynch on the NYSE, has an aggregate market value of $298,741.99 and involves stock previously received as equity compensation awards.

How many Zoetis (ZTS) shares are being proposed for sale under Rule 144?

The notice covers a proposed sale of 2,346 Zoetis common shares. These shares are to be sold through Merrill Lynch on the NYSE, with the filing listing an aggregate market value of $298,741.99 for this planned transaction by the reporting insider.

Who is the selling security holder in this Zoetis (ZTS) Form 144?

The selling security holder is identified as Robert Polzer. The filing shows his address in Parsippany, New Jersey, and indicates that the shares to be sold were acquired through vesting of Zoetis equity compensation awards such as restricted stock units and performance share awards.

When were the Zoetis (ZTS) shares to be sold under Form 144 acquired?

The shares were acquired on several vesting dates: February 12, 2022 and February 8, 2025. They resulted from vested restricted stock unit awards and performance share awards granted as part of the Zoetis issuer equity compensation plan to the reporting person.

What prior Zoetis (ZTS) stock sales has the insider reported in the last three months?

The filing reports that Robert Polzer sold 3,662 shares of Zoetis common stock on February 13, 2026. Those sales generated gross proceeds of $472,727.58 and are disclosed as required for securities sold during the past three months.

On which exchange will the Zoetis (ZTS) Form 144 shares be sold?

The proposed Rule 144 sale is listed for execution on the NYSE. Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, is named as the broker handling the 2,346 Zoetis common shares to be sold for the reporting person.